Drug Type Herbal medicine |
Synonyms KYG-0395 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (27 Apr 2020), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Breast Diseases | China | 27 Apr 2020 | |
Dysmenorrhea | China | 27 Apr 2020 | |
Neoplasms | China | 27 Apr 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary dysmenorrhea | Phase 2 | United States | 01 May 2012 |
Phase 2 | 280 | Placebo | plqlwxeufc(kihtldgixu) = wtkvoakqey ioyudrozat (smjaaclpnw, 2.86) View more | - | 26 Mar 2019 |